Chinese | English

Search in the results

HFCAS OpenIR

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Association Between Neuroticism and Risk of Lung Cancer: Results From Observational and Mendelian Randomization Analyses 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
Authors:  Wei, Xiaoxia;  Jiang, Xiangxiang;  Zhang, Xu;  Fan, Xikang;  Ji, Mengmeng;  Huang, Yanqian;  Xu, Jing;  Yin, Rong;  Wang, Yuzhuo;  Zhu, Meng;  Du, Lingbin;  Dai, Juncheng;  Jin, Guangfu;  Xu, Lin;  Hu, Zhibin;  Hang, Dong;  Ma, Hongxia
Favorite  |  View/Download：66/0  |  Submit date：2022/03/28
lung cancer  neuroticism  genetic risk  prospective analysis  Mendelian randomization study  
Circulating C-reactive protein increases lung cancer risk: Results from a prospective cohort of UK Biobank 期刊论文
INTERNATIONAL JOURNAL OF CANCER, 2021
Authors:  Ji, Mengmeng;  Du, Lingbin;  Ma, Zhimin;  Xie, Junxing;  Huang, Yanqian;  Wei, Xiaoxia;  Jiang, Xiangxiang;  Xu, Jing;  Yin, Rong;  Wang, Yuzhuo;  Dai, Juncheng;  Jin, Guangfu;  Xu, Lin;  Zhu, Chen;  Hu, Zhibin;  Ma, Hongxia;  Zhu, Meng;  Shen, Hongbing
Favorite  |  View/Download：57/0  |  Submit date：2021/11/01
C-reactive protein  chronic inflammation  lung cancer  Mendelian randomization  prediagnostic marker  
Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
Authors:  He, Chiyu;  Qian, Yu;  Liu, Bin;  Yang, Shaoxue;  Ye, Ding;  Sun, Xiaohui;  Chen, Tianhui;  Mao, Yingying
Favorite  |  View/Download：95/0  |  Submit date：2020/12/28
C-reactive protein  genome-wide association study  Mendelian randomization  prostate cancer  single-nucleotide polymorphisms  
Genetically predicted levels of circulating cytokines and prostate cancer risk: A Mendelian randomization study 期刊论文
INTERNATIONAL JOURNAL OF CANCER, 2020
Authors:  Sun, Xiaohui;  Ye, Ding;  Du, Lingbin;  Qian, Yu;  Jiang, Xia;  Mao, Yingying
Favorite  |  View/Download：56/0  |  Submit date：2020/11/26
cytokines  inflammation  Mendelian randomization  monocyte chemotactic protein-1  prostate cancer